Log in
Enquire now

List of Exonhit Therapeutics patents

List of Exonhit Therapeutics patents
List of Vigene Biosciences patents
List of Bemis Manufacturing Company patents
List of 3-V Biosciences patents
List of SBIR/STTR awards granted to Opotek
List of SBIR/STTR awards granted to BIOMEDICA MANAGEMENT CORP.
Patents where
Current Assignee
Name
is
‌
Exonhit Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7514432 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis

Patent 7514432 was granted and assigned to Exonhit Therapeutics on April, 2009 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7514432
April 7, 2009
‌
US Patent 7872015 Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies

Patent 7872015 was granted and assigned to Exonhit Therapeutics on January, 2011 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7872015
January 18, 2011
‌
US Patent 8003375 Qualitative differential screening

Patent 8003375 was granted and assigned to Exonhit Therapeutics on August, 2011 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8003375
August 23, 2011
‌
US Patent 7790864 Antibody to BACE455, an alternative splice variant of the human beta-secretase

Patent 7790864 was granted and assigned to Exonhit Therapeutics on September, 2010 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7790864
September 7, 2010
‌
US Patent 7923579 Tricyclic hydroxamate and benzamide derivatives, compositions and methods

Patent 7923579 was granted and assigned to Exonhit Therapeutics on April, 2011 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7923579
April 12, 2011
‌
US Patent 7834163 Prostate specific genes and the use thereof as targets for prostate cancer therapy

Patent 7834163 was granted and assigned to Exonhit Therapeutics on November, 2010 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7834163
November 16, 2010
‌
US Patent 8481701 Process and method for diagnosing Alzheimer's disease

Patent 8481701 was granted and assigned to Exonhit Therapeutics on July, 2013 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8481701
July 9, 2013
‌
US Patent 6855736 Molecular target of neurotoxicity

Patent 6855736 was granted and assigned to Exonhit Therapeutics on February, 2005 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
6855736
February 15, 2005
‌
US Patent 6881571 Qualitative differential screening

Patent 6881571 was granted and assigned to Exonhit Therapeutics on April, 2005 by the United States Patent and Trademark Office.

‌
Exonhit Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
6881571
April 19, 2005
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us